These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 9269289)

  • 61. Problems in the investigation of adverse reactions.
    Freestone DS
    Dev Biol Stand; 1979; 43():439-42. PubMed ID: 391632
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Surveillance of adverse events following immunisation in Australia annual report, 2014.
    Dey A; Wang H; Quinn HE; Hill R; Macartney KK
    Commun Dis Intell Q Rep; 2016 Sep; 40(3):E377-E390. PubMed ID: 28278414
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Acute disseminated encephalomyelitis onset: evaluation based on vaccine adverse events reporting systems.
    Pellegrino P; Carnovale C; Perrone V; Pozzi M; Antoniazzi S; Clementi E; Radice S
    PLoS One; 2013; 8(10):e77766. PubMed ID: 24147076
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Disease-related adverse events following non-live vaccines: investigation of a newly described reporting bias through the analysis of the WHO Global ICSR Database, VigiBase.
    Roberto G; Zanoni G
    Vaccine; 2014 May; 32(26):3328-35. PubMed ID: 24291198
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Anaphylaxis as an adverse event following immunisation in the UK and Ireland.
    Erlewyn-Lajeunesse M; Hunt LP; Heath PT; Finn A
    Arch Dis Child; 2012 Jun; 97(6):487-90. PubMed ID: 22275307
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Surveillance of adverse events following immunisation in Australia annual report, 2016.
    Dey A; Wang H; Quinn H; Cook J; Macartney K
    Commun Dis Intell (2018); 2018; 42():. PubMed ID: 30626306
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Safety assessment post-licensure.
    Miller E; Waight P; Farrington P
    Dev Biol Stand; 1998; 95():235-43. PubMed ID: 9855437
    [TBL] [Abstract][Full Text] [Related]  

  • 68. New Zealand immunisation schedule history.
    Dow DA; Mansoor O
    N Z Med J; 1996 Jun; 109(1023):209-12. PubMed ID: 8668301
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Centre for Adverse Reactions Monitoring report for the year ending 30 June, 1994.
    Pillans PI; Coulter DM
    N Z Med J; 1995 Nov; 108(1012):488-91. PubMed ID: 8538979
    [No Abstract]   [Full Text] [Related]  

  • 70. Cutaneous adverse reactions following anti-infective vaccinations.
    Nikkels AF; Nikkels-Tassoudji N; Piérard GE
    Am J Clin Dermatol; 2005; 6(2):79-87. PubMed ID: 15799679
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Signal detection for vaccine side effects that have not been specified in advance.
    Walker AM
    Pharmacoepidemiol Drug Saf; 2010 Mar; 19(3):311-7. PubMed ID: 20014170
    [TBL] [Abstract][Full Text] [Related]  

  • 72. The reporting sensitivities of two passive surveillance systems for vaccine adverse events.
    Rosenthal S; Chen R
    Am J Public Health; 1995 Dec; 85(12):1706-9. PubMed ID: 7503351
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Adverse events temporally associated with vaccines--1992 report.
    Bentsi-Enchill A; Hardy M; Koch J; Duclos P
    Can Commun Dis Rep; 1995 Jul; 21(13):117-28. PubMed ID: 7663460
    [No Abstract]   [Full Text] [Related]  

  • 74. Adverse events temporally associated with immunizing agents--1989 report.
    Duclos P; Koch J; Hardy M; Carter A; McCarthy R
    Can Dis Wkly Rep; 1991 Jul; 17(29):147-51, 155-7. PubMed ID: 1913934
    [No Abstract]   [Full Text] [Related]  

  • 75. Global and Regional Burden of Vaccine-Associated Erythema Multiforme and Their Related Vaccines, 1967-2023: An In-Depth Analysis of the World Health Organization Pharmacovigilance Database.
    Kyung S; Rahmati M; Kang J; Lee K; Lee H; Yon DK
    Med Princ Pract; 2024 Oct; ():1-14. PubMed ID: 39369714
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Nationwide vaccine adverse events reporting system.
    Nightingale SL
    Am Fam Physician; 1991 Mar; 43(3):1053-4. PubMed ID: 2000717
    [No Abstract]   [Full Text] [Related]  

  • 77. Vaccine-adverse event reporting system: an essential tool for monitoring vaccine safety.
    Hayney MS
    J Am Pharm Assoc (2003); 2006; 46(2):298-9. PubMed ID: 16602234
    [No Abstract]   [Full Text] [Related]  

  • 78. Accidental self inoculation with oil based veterinary vaccines.
    Jones DP
    N Z Med J; 1996 Sep; 109(1030):363-5. PubMed ID: 8890863
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Doctors in the private sector should report adverse events after immunisation to complete dataset.
    Bhaumik S
    BMJ; 2013 Aug; 347():f4968. PubMed ID: 23924657
    [No Abstract]   [Full Text] [Related]  

  • 80. [Adverse events following immunization and causality assessment of an adverse event following immunization].
    Yao KH; Yang YH
    Zhongguo Dang Dai Er Ke Za Zhi; 2014 Jan; 16(1):1-4. PubMed ID: 24461168
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.